retatrutide obesity triple hormone receptor agonist Triple-Hormone-Receptor for... : New England Journal of Medicine Retatrutide: A Triple Agonist Shaping

Phase 2 trial data shows up to 24.2% body weight reduction at the 12mg dose over 48 weeks

Ozempic is approved for type 2 diabetes, but is sometimes used off-label for weight loss, and Wegovy is approved for weight loss, heart disease, and MASH

No large-scale phase 3 trials have been completed

Several studies have examined diet-induced changes in gut microbiota in mice strains fed a high fat or high sucrose diet and, in each case, a significant proportional increase in Firmicutes and decrease in Bacteroidetes was seen ( Dorea and Eubacterium rectale and decreased Bifidobacterium ( Firmicutes and reduced Bacteroidetes : Eubacterium rectale in obese individuals ( Gut barrier dysfunction and endotoxemia Intestine is one of the most crucial internal barriers and its disturbance leads to an immune response as bacterial products pass through the gut, and evidence shows that the immune systems of patients with MASLD are primed toward a pro-inflammatory state

If you add 2 mL (or 2cc) of Bacteriostatic Water to a 10mg vial, your final concentration will be 5mg per mL (10mg / 2mL = 5mg/mL)